Discovery Technologies

Immunization Strategies

Genovac’s core technology, genetic immunization, enables the development of antibodies against any protein target directly from DNA, an electronic sequence, or an accession number.

 

Find out more

Single B Cell Platforms

Genovac is the premier research partner offering two complimentary automated single B cell antibody discovery platforms for rare antibody discovery; Berkeley Lights’ Beacon single B cell screening and selection platform and the Genovac Nano platform.

Find out more

Advanced Hybridoma

Highly efficient semi-solid and well-based fusion options provide rapid delivery of antibodies that are comparable to yields of manual single B cell platforms.

Find out more

Antibody Sequencing

Genovac offers in-house hybridoma and single B cell antibody sequencing.

Find out more

Transgenic Animal Partners

Genovac is an approved contract research provider with all leading transgenic animal companies.

Find out more